Headlines about Clorox Company (The) (NYSE:CLX) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Clorox Company (The) earned a news impact score of 0.22 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3460733267775 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the news headlines that may have impacted Accern’s scoring:

Clorox Company (CLX) traded down 0.20% during midday trading on Thursday, reaching $133.94. 507,862 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $133.88 and its 200-day moving average price is $133.46. The stock has a market cap of $17.29 billion, a PE ratio of 25.11 and a beta of 0.40. Clorox Company has a one year low of $111.24 and a one year high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the company earned $1.30 EPS. Clorox Company (The)’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts predict that Clorox Company will post $5.68 earnings per share for the current year.

A number of equities analysts recently weighed in on the stock. UBS AG reissued a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Jefferies Group LLC reissued a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. BMO Capital Markets set a $150.00 price target on shares of Clorox Company (The) and gave the stock a “buy” rating in a report on Thursday, August 3rd. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $129.05.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Given Daily Media Sentiment Rating of 0.22” was posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/10/clorox-company-the-clx-given-daily-media-sentiment-rating-of-0-22.html.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.